News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
120
Sources here
15
Companies here
6
Search results Stored financial headlines

Active search

120 matching headlines

Ticker or company: NICEMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

NICE Systems Number of Employees 2026 | Employee Count & Headcount Data

NICE Systems, Inc. had approximately 8,187 employees worldwide as of March 2026, marking a 20.0% growth since 2023. The company is actively hiring, with 555 job postings in 2026, and its workforce is predominantly located in India (38.7%), followed by the United States (25.7%). …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RBC Capital Maintains NICE Ltd(NICE.US) With Buy Rating, Maintains Target Price $130

RBC Capital has reiterated its Buy rating for NICE Ltd (NICE.US) and maintained its target price at $130. This suggests the firm continues to see strong potential for the company's stock.

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell (OMCL) Could Be 30% Undervalued If Its OmniSphere Shift Pays Off

Omnicell (OMCL) is attracting attention due to recent share price movements and its strategic shift towards the cloud-native OmniSphere platform, which aims to simplify medication management and boost recurring SaaS-based revenues. While a popular narrative suggests the company is 29.8% undervalued with a fair …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NICE Ltd. Sponsored ADR Revenue Breakdown – MUN:NSY

NICE Ltd. Sponsored ADR (MUN:NSY) reported its financial performance, with total revenue reaching ‪2.51 billion EUR last year. The Customer Engagement segment was the primary revenue driver, contributing ‪2.09 billion EUR. Geographically, the Americas, primarily the United States, was the largest contributor, accounting for …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nice Ltd (NICE) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nice Ltd (NICE), detailing its current support and resistance levels, key technical indicators, and moving averages. The stock's price momentum score is 4.27, suggesting it is suitable for range-bound swing trading between resistance at 108.94 and support …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NICE Actimize Positioned as a Luminary in Celent’s 2026 "Know Your Customer Systems: Adverse Media Screening" Report

NICE Actimize's solution applies Agentic AI to produce article-level summaries, sentiment and relevancy to surface key risk indicators and context quickly HOBOKEN, N.J., July 27, 2026--(BUSINESS WIRE)--NICE Actimize, a NiCE (NASDAQ: NICE) business, has been recognized by Celent, a global research and advisory firm …

N1IC34 main company NICE main company NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -32.1% · Next-week setup negative 24.5% N1IC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nice Ltd (NICE) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Nice Ltd (NICE) stock, focusing on dividend distributions. It states that NICE has distributed $0.00 in dividends over the past five years and that no specific dividend payout dates are available. The page includes current stock performance data …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Omnicell Inc (OMCL) currently has an earnings forecast score of 8.00, placing it 68th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $47.00, with a majority recommending a "Buy" trend for the stock. The company's expected revenue …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NICE|Nice Ltd|Price:95.050|Chg%:+4.790

Nice Ltd (NICE) has a strong financial outlook with high growth potential, fair valuation, and very high institutional ownership. Analysts have rated it as a Buy, with the highest price target at 131.08. The stock price is currently trading sideways, making it suitable for …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell Inc (OMCL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Omnicell Inc (OMCL), noting its current valuation score of 6.66, ranking 178 out of 200 in the Healthcare Equipment & Supplies industry. The company's P/E ratio stands at 91.94, which is significantly below its recent high but …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell Inc (OMCL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Omnicell Inc (OMCL) stock, including its current trading price, market capitalization, and P/E ratio. It specifically addresses the company's dividend history, noting that no dividends have been distributed over the past five years. The page indicates there is …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OMCL|Omnicell Inc|Price:39.845|Chg%:-1.015

Omnicell Inc. (OMCL) is a provider of medication management solutions and adherence tools for health systems and pharmacies, focusing on transforming pharmacy care through innovation. The company's solutions utilize robotics, smart devices, intelligent software, and services to optimize clinical and business outcomes. Omnicell's offerings …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NICE Ltd. (NICE.TA) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive information on NICE Ltd. (NICE.TA), including its current stock price, historical data, key statistics, and company overview. NICE Ltd. specializes in AI-powered cloud platforms for customer engagement, and financial crime and compliance. The page also features performance comparisons, …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to book forward of Omnicell, Inc. – BX:OC9

This article provides the "Price to book forward" financial metric for Omnicell, Inc. (BX:OC9). It appears to be a stub or data-focused page from TradingView, indicating the value and changes for this specific financial ratio over a period. The page also lists various related …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Morgan Stanley Downgrades NICE Ltd(NICE.US) to Hold Rating, Cuts Target Price to $111

Morgan Stanley has downgraded NICE Ltd (NICE.US) to a "Hold" rating from its previous "Overweight" rating. Simultaneously, the firm reduced its price target for NICE Ltd shares to $111 from $130. This adjustment reflects a more cautious outlook on the company's stock performance.

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rosenblatt Securities Maintains NICE Ltd(NICE.US) With Buy Rating, Cuts Target Price to $130

Rosenblatt Securities has reiterated its Buy rating on NICE Ltd (NICE.US) despite reducing its price target from $165 to $130. This adjustment reflects a moderation in expectations for the company's annual recurring revenue (ARR) and organic growth, although the analyst maintains a positive long-term …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NiCE Provides Webcast and Dial-in Details for its Second Quarter 2026 Results Teleconference

NiCE (Nasdaq: NICE) announced that it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, before the NASDAQ Stock Exchange opens. Following the release, the company will host a conference call and webcast to discuss these results. Details for accessing …

NICE main company NICE main company
Sharemaestro market context Price above Trend Line 52 weeks -32.6% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell (OMCL) Stock Forum and Discussion

This article provides a forum for discussion regarding Omnicell (OMCL) stock. It includes a basic stock quote for OMCL, showing its last price, change, and percentage change. The article encourages users to share their opinions and insights on Omnicell's future performance.

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell to Report Q2 Earnings: OmniSphere in Focus

Omnicell (OMCL) is scheduled to release its second-quarter 2026 earnings on July 30, with expectations for revenue growth to reach $309.6 million and earnings per share of 48 cents. The company's performance is anticipated to be driven by its Connected Devices strategy, expanding recurring …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nice (NICE) Gains As Market Dips: What You Should Know

Nice (NICE) closed the most recent trading day at $101.34, moving +1.19% from the previous trading session. This change outpaced the S&P 500's 0.19% loss on the day. Meanwhile, the Dow experienced a drop of 0.59%, and the technology-dominated Nasdaq saw a decrease of …

N1IC34 main company NICE main company NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -32.1% · Next-week setup negative 24.5% N1IC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nice (NICE) is Attracting Investor Attention: Here is What You Should Know

Nice (NICE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this software company have …

N1IC34 main company NICE main company NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -32.1% · Next-week setup negative 24.5% N1IC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(OMCL) Risk Channels and Responsive Allocation

This article provides an analysis of Omnicell Inc. (OMCL), highlighting strong sentiment across all time horizons supporting an overweight bias. It details an exceptional 57.2:1 risk-reward setup targeting a 16.8% gain versus a 0.3% risk. The analysis also outlines three distinct AI-generated institutional trading …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NICE (NICE) Investor Day 2024 Summary

NICE's 2024 Investor Day highlighted its strategic focus on customer experience, financial crime, and criminal justice platforms, leveraging AI and cloud solutions like CXone. The company reported strong financial performance with double-digit growth in revenue, operating income, and free cash flow over the past …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NICE (NICE) Q2 2025 earnings summary

NICE (NICE) reported robust Q2 2025 results with revenue up 9% YoY to $727 million, driven by strong cloud growth and a 42% YoY increase in AI/self-service ARR. The company exceeded revenue guidance and achieved EPS at the high end of its range, demonstrating …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Omnicell (OMCL) chief reports 10,000-share sale at $47 via trust

Omnicell, Inc. CEO Randall A. Lipps reported an indirect sale of 10,000 shares of common stock at $47.00 per share on July 15, 2026, executed through a Rule 10b5-1 trading plan adopted in February 2026. The shares were held in a trust with his …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

If You Invested $1,000 in Nice Ltd (NCSYF)

This article analyzes hypothetical investment returns for Nice Ltd (NCSYF). It shows that a $1,000 investment made one year ago would now be worth $521, representing a -47.9% total return. The company is identified as an Israel-based technology firm focused on customer experience, AI, …

NICE main company
Sharemaestro market context Price below Trend Line 52 weeks -28.2% NICE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

[144] OMNICELL, INC. SEC Filing

This article details an SEC Form 144 filing by Omnicell, Inc. concerning the proposed sale of 10,000 shares of common stock with an aggregate market value of $470,000. The shares were acquired by "Common Merrill Lynch" on January 16, 2021, through equity compensation. The …

OMCL main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% OMCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context